Robuta

https://pmc.ncbi.nlm.nih.gov/articles/PMC11652361/ Siglec15 in blood system diseases: from bench to bedside - PMC Inhibiting the PD-1/PD-L1 pathway using immunomodulators has demonstrated promising outcomes in clinics. Immunomodulators can effectively target immune... bench to bedsideblood systemsiglec15diseasespmc https://www.semanticscholar.org/topic/SIGLEC15-gene/6092643 SIGLEC15 gene | Semantic Scholar siglec15genesemanticscholar